HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

NU172

currently in Phase II as anticoagulant in heart disease treatments

Also Known As:

NU172 anti-thrombin aptamer

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleotides: 15763
  - Polynucleotides: 218
    - Oligonucleotides: 5145
      - Nucleotide Aptamers: 598
        NU172: 2

Experts

1.	Avci-Adali, Meltem: 1 article (12/2019)
2.	Fennrich, Stefan: 1 article (12/2019)
3.	Haag, Hanna: 1 article (12/2019)
4.	Hann, Ludmilla: 1 article (12/2019)
5.	Kunnakattu, Silju-John: 1 article (12/2019)
6.	Kurz, Julia: 1 article (12/2019)
7.	Rauch, Nicole: 1 article (12/2019)
8.	Schlensak, Christian: 1 article (12/2019)
9.	Stoppelkamp, Sandra: 1 article (12/2019)
10.	Wendel, Hans-Peter: 1 article (12/2019)

Related Diseases

1.	Thrombocytopenia (Thrombopenia) 12/25/2019 - "Thrombin aptamers such as NU172 might be used during extracorporeal circulation (ECC) in combination with a reduced heparin concentration or for patients with heparin-induced thrombocytopenia (HIT). "
2.	Heart Diseases (Heart Disease) 12/14/2018 - "Among them, NU172 is currently in Phase II as anticoagulant in heart disease treatments. "

Related Drugs and Biologics

1.	Thrombin
2.	Heparin (Liquaemin)
3.	Anticoagulants

Related Therapies and Procedures

1.	Extracorporeal Circulation